Arbor Rapha Capital Bioholdings Corp. I: Nasdaq/NYSE listing notice — Arbor Rapha Capital Bioholdings Corp. I to be delisted from Nasdaq on Jan 24 after 99.6% stock redemption

Arbor Rapha Capital Bioholdings Corp. I

Nasdaq notified company on Jan 13, 2023 of non-compliance with market value and publicly held shares requirements.
Stockholders redeemed 17,188,668 Class A shares (approx. 99.6%) at Dec 8, 2022 special meeting, triggering delisting.
Nasdaq halted trading on Jan 12, 2023; delisting effective open of business Jan 24, 2023.
Company expects Securities (common, warrants, units) to trade over-the-counter after delisting.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Arbor Rapha Capital Bioholdings Corp. I received a nasdaq delisting notice notice regarding other (rules 5450(b)(2)(B), 5450(b)(2)(A), 5450(b)(2)(C), 5450(b)(1), 5450(b)(3), 5550, 5101).

Exchange: nasdaq
Notice: delisting notice
Rules: 5450(b)(2)(B), 5450(b)(2)(A), 5450(b)(2)(C), 5450(b)(1), 5450(b)(3), 5550, 5101

Exact text from the filing

January 13, 2023, Arbor Rapha Capital Bioholdings Corp. I (the “Company”) received a letter from the Listing Qualifications Staff (the “Staff’) of the Nasdaq Stock Market LLC (“Nasdaq”), which stated that the Company was not in compliance with the requirements of Nasdaq Listing Rules (i) 5450(b)(2)(B), requiring a minimum of $50 million Market Value of Listed Securities requirement (the “Market Value Requirement”); (ii) 5450(b)(2)(A), requiring a minimum 1,100,000 Publicly Held Shares (the “Publicly Held Shares Requirement”), and (iii) 5450(b)(2)(C), requiring a minimum of $15 million Market V

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001104659-23-004613

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.